About Viseon
Viseon is a company based in Irvine (United States) founded in 2017 by Alex Thomson. Viseon has raised $29.45 million across 2 funding rounds from investors including Invus. Viseon offers products and services including MaxView®. Viseon operates in a competitive market with competitors including Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
- Headquarter Irvine, United States
- Founders Alex Thomson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Viseon, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.45 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viseon
Viseon offers a comprehensive portfolio of products and services, including MaxView®.
Provides 4K video for enhanced visualization in spine surgery.
Funding Insights of Viseon
Viseon has successfully raised a total of $29.45M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Viseon
Viseon has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked |
Investor details for Viseon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viseon
Investment portfolio details for Viseon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Viseon
Detailed financials for Viseon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viseon Comparisons
Peer comparison for Viseon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viseon
Viseon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Developer of surgical navigation and image guidance system for endovascular procedures
|
Detailed competitors of Viseon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viseon
Complete news archive for Viseon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viseon
Viseon was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Viseon is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Jeffrey Valko is the current CEO of Viseon.
Viseon is a funded company, having raised a total of $29.45M across 2 funding rounds to date.
Viseon was founded in 2017 and is headquartered in Irvine, United States. Digital visualization solutions for minimally invasive spine surgery are offered by the company within the medical technology sector. Products such as the MaxView 4K Video Imaging Platform, MaxView Posterior, and MaxView 4K Imager are provided to support visualization, video recording, and signal routing during surgical procedures. Operations focus on enhancing surgical precision through advanced imaging technologies.
Viseon's top competitors include Augmedics, Proprio and ClearPoint Neuro.
Viseon offers MaxView®.
Viseon has 1 investor. Key investors include Invus.